Senior insider sale
Chief Scientific Officer at MONTE ROSA THERAPEUTICS, INC. — senior position signals high conviction
$240.0K
20K shares
What this filing means
WALLACE OWEN B. plans to sell 20K shares of MONTE ROSA THERAPEUTICS, INC. valued at approximately $240.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/28/2024ACC: 0001973141-24-000523
Officer· Chief Scientific Officer
Since Jun 2021
20K
Shares to sell
$240.0K
Approx. market value
20K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Option
Cash
10/28/2024
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/28/2024 | Exercise of Stock Option Cash | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
20K
Market value
$240.0K
10/28/2024
Total
Units
20K
Value
$240.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/28/2024 | 20K | $240.0K | Nasdaq | Planned |
| Total | 20K | $240.0K | ||